1. Ideal for the smallest patients „„Short inhalation time - less than 7 min. (with salbutamol) for 2.5 ml Inhalation Solution Equipment for babies from the first months of age: BABY mask, BABY bend „„Effective inhalation with PARI LC SPRINT Junior Nebuliser and fine droplets for the smaller airways of babies and infants „„ No specific inhalation technique required PARI JuniorBOY SX is ideal for treating babies as young as one month as effectively as possible. It can be used to treat illnesses such as bronchial asthma asthma Asthma is a common chronic inflammatory airway disease, characterized by variable and recurring symptoms, reversible airflow obstruction and bronchospasm., allergic asthma asthma Asthma is a common chronic inflammatory airway disease, characterized by variable and recurring symptoms, reversible airflow obstruction and bronchospasm. as well as acute and chronic bronchitis bronchitis Bronchitis is an inflammation of the bronchi, the larger and medium-sized air passages of the lung.. The configuration and aerosol aerosol An aerosol is a colloid of fine solid particles or liquid droplets, in air or another gas. properties of PARI JuniorBOY SX have been specially adapted to meet the special needs of small patients. The PARI LC SPRINT Junior Nebuliser which is delivered with the PARI JuniorBOY SX generates particularly small aerosol aerosol An aerosol is a colloid of fine solid particles or liquid droplets, in air or another gas. droplets. As the lower airways of children are narrower than is the case with adults, this is necessary to deliver a therapeutically effective dose to the lungs. A baby mask for the treatment of babies and small children is supplied also. The flexible connection piece furthermore can be used to position the soft, well-fitting mask. Therefore it enables a comfortable and effective inhalation either sitting or lying down. A mouth piece is supplied for use by children from 3 years on. Aerosol characteristics (yellow nozzle): Total Output Rate: 320 mg/min FPF 76% R 2 179.03 (SEP excl. VAT) PARI JuniorBOY SX

2. Ideal for everyone over 4 years old Short inhalation time – less than 5 min. (with salbutamol) for 2.5 ml Inhalation Solution PARI LC SPRINT Nebuliser ensures efficient lung deposition even with short inhalation times The nebuliser is easy to use – even for the youngest children With masks for children and adults PARI TurboBOY SX is ideal for the treatment of the lower airways in children, youths and adults. It can be used to treat illnesses such as bronchial asthma asthma Asthma is a common chronic inflammatory airway disease, characterized by variable and recurring symptoms, reversible airflow obstruction and bronchospasm., allergic asthma asthma Asthma is a common chronic inflammatory airway disease, characterized by variable and recurring symptoms, reversible airflow obstruction and bronchospasm. as well as acute and chronic bronchitis bronchitis Bronchitis is an inflammation of the bronchi, the larger and medium-sized air passages of the lung.. The PARI LC SPRINT nebuliser which is delivered with the PARI TurboBOY SX ensures efficient lung deposition and correspondigly short inhalation times. For those patients for whom treatment with a mouthpiece is not suitable, comfortable masks for both children and adults are included in the package. Aerosol characteristics (blue nozzle): Total Output Rate: 500 mg/min FPF 68 % R 2 051.71 (SEP excl. VAT) PARI TURBOBOY SX

3. Modern inhalation treatment - twice as fast! The eFlow rapid nebuliser system is an innovative appliance for the treatment of respiratory diseases. Throughout its development, particular care was taken to consider patients' needs for efficient, safe, and above all fast inhalation treatment Short treatment times Quiet running for discrete use Light, compact and portable. Can be run on either batteries or mains power for greater mobility Easy to clean, handset can be disinfected and autoclaved for the highest standards of hygiene New display delivers feedback during inhalation With a time saving of more than 50% and its noiseless - thus unobtrusive - operation, the eFlow rapid can be beneficial to cystic fibrosis patients. With the eFlow rapid, medications that have been approved for inhalation can be transported deep into the lungs quickly and efficiently. The eFlow rapid is suitable for all medications that have been approved for use and are available throughout Europe. It also offers worldwide portability and unparalleled hygiene reliability. Components: 2 complete nebulisers 2.0 (incl. aerosol aerosol An aerosol is a colloid of fine solid particles or liquid droplets, in air or another gas. head 2.0), easycare cleaning aid, control unit with batteries, connection cord, international power adapter with four interchangeable adapters, a carrying case and nebuliser bag. Aerosol characteristics: Total Output Rate: 500 mg/min FPF 64% R 8 794.80 (SEP excl. VAT) EFLOW RAPID NEBULISER SYSTEM